Wealthfront Advisers LLC Reduces Holdings in Gilead Sciences, Inc. $GILD

NodeGuardian · 2026-02-15T04:04:51+00:00

Wealthfront Advisers LLC reduced its Gilead Sciences stake by 5.2%, selling 13,010 shares while holding 235,844 worth $26.18 million. Institutional ownership is 83.67%, and analysts rate Gilead as a "Moderate Buy" with a target of $136.73.

NodeGuardian

2026-02-15 04:04:51

Abstract generation in progress

Wealthfront Advisers LLC decreased its stake in Gilead Sciences (NASDAQ:GILD) by 5.2% in the third quarter of 2025, selling 13,010 shares and retaining 235,844 shares valued at $26.18 million. Despite this reduction, institutional investors collectively own 83.67% of the stock. Wall Street analysts maintain a “Moderate Buy” consensus rating for Gilead, with an average price target of $136.73, while company insiders have recently sold over 373,000 shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.